Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TRAWTRAW
7 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in TRAWS PHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 111,365 shares of TRAW (TRAWS PHARMA INC), worth $93,915 as of 2026-Q2. The position was increased (+44.4% shares).

Current Value

$93,915

Current Shares

111,365

Total Value Change

-$90,812

Total Shares Change

+90,564

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
111,365
+44.4%
$93,9150.0%$0.84
20
2026-Q1
Increased
77,103
+25.1%
$141,1000.0%$1.65
19
2025-Q4
Increased
61,653
+41.9%
$69,6680.0%$1.09
19
2025-Q3
Increased
43,440
+21.6%
$80,3660.0%$1.89
17
2025-Q2
Increased
35,725
+7.0%
$52,8740.0%$1.43
15
2025-Q1
Increased
33,379
+60.5%
$76,7750.0%$2.40
21
2024-Q4
New
20,801
-
$184,7270.0%$8.42
35

Other major holders of TRAW: ADAGE CAPITAL PARTNERS GP, L.L.C., Alyeska Investment Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used